Medication Access
6 articles on Medication Access, written by Shotlee and medically reviewed for clinical accuracy.
Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies
Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.
7 min read
Pharmac Funding for Wegovy: What NZ Patients Need to Know
New Zealand's Pharmac funding agency has moved semaglutide (Wegovy) to its investment list. Here is what this means for eligibility, costs, and access.
8 min read
Hims & Hers Downgrade: What It Means for GLP-1 Weight Loss Access
Bank of America cuts Hims & Hers price target as the telehealth giant pivots from compounded GLP-1s to branded alternatives. Here is what this shift means for patients.
8 min read
Hims & Hers Q1 Earnings: What It Means for GLP-1 Access & Weight Loss
Hims & Hers reports Q1 results. See how financial growth and regulatory shifts affect patient access to semaglutide, tirzepatide, and peptide therapy.
7 min read
Amazon Stocks Oral Ozempic Pills: Same-Day Delivery & Pricing Guide
Amazon Pharmacy is expanding access to oral GLP-1 medications like Ozempic and Wegovy through kiosks and same-day delivery. Here is everything you need to know about pricing, logistics, and managing your treatment.
7 min read
CVS 2026 Outlook: Impact on GLP-1 Coverage, Insurance, and Care Access
CVS Health exceeded earnings expectations, but what does this mean for patients using GLP-1 medications like Ozempic or Wegovy? We break down the financial news and its real-world implications for your healthcare coverage.
8 min read